Recommended Epinephrine Dosage for Anaphylaxis
For anaphylaxis treatment, administer epinephrine via intramuscular injection in the mid-outer thigh (vastus lateralis) with a dose of 0.3-0.5 mg for adults and children ≥30 kg, and 0.01 mg/kg (maximum 0.3 mg) for children <30 kg. 1
Dosage Guidelines by Age/Weight
Adults and Children ≥30 kg (66 lbs):
- Dose: 0.3-0.5 mg epinephrine
- Concentration: 1:1000 (1 mg/mL)
- Volume: 0.3-0.5 mL
- Route: Intramuscular injection into the anterolateral aspect of the thigh
- Frequency: Every 5-10 minutes as necessary if symptoms persist 1, 2
Children <30 kg (66 lbs):
- Dose: 0.01 mg/kg, up to maximum 0.3 mg
- Concentration: 1:1000 (1 mg/mL)
- Volume: 0.01 mL/kg, up to maximum 0.3 mL
- Route: Intramuscular injection into the anterolateral aspect of the thigh
- Frequency: Every 5-10 minutes as necessary if symptoms persist 1, 2
Specific Weight-Based Recommendations for Children
- For children weighing 10-25 kg (22-55 lbs): 0.15 mg epinephrine autoinjector
- For children weighing ≥25 kg (≥55 lbs): 0.3 mg epinephrine autoinjector 3
Administration Considerations
Route of Administration
- Intramuscular (IM) injection into the lateral thigh (vastus lateralis) is the preferred route for first-line treatment 3, 1
- Avoid injection into buttocks, digits, hands, or feet due to risk of tissue damage 2
- Intravenous administration should only be considered in severe cases by experienced providers in monitored settings due to increased risk of adverse effects 4
Timing
- Administer epinephrine as early as possible once anaphylaxis is recognized 1
- Delayed administration is associated with increased mortality 1
- Never delay epinephrine administration while giving secondary medications 1
Important Clinical Pearls
Patient Positioning
- Position patients with hypotension in a supine position with legs elevated 1
- Avoid standing or walking during acute anaphylaxis as this can worsen hypotension 1
Monitoring and Follow-up
- Monitor patients closely for at least 4-6 hours for potential biphasic reactions 1
- Be prepared to administer additional doses if symptoms persist or worsen 1
Common Pitfalls to Avoid
- Incorrect route: Subcutaneous administration has delayed onset compared to IM injection 4
- Incorrect dose: Using cardiac arrest dosing (1:10,000 concentration) instead of anaphylaxis dosing (1:1000 concentration) 5, 6
- Delayed administration: Waiting for other medications or complete symptom development before giving epinephrine 1
- Inappropriate contraindications: There are no absolute contraindications for epinephrine use in anaphylaxis, even in patients with cardiovascular disease 1
Remember that epinephrine is the cornerstone of anaphylaxis management, and prompt administration can be life-saving. Failure to inject epinephrine promptly is a significant contributor to anaphylaxis fatalities 4.